Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: RNA degradation (mmu03018)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1700080E
11Rik
KLA  ATP  ATP+KLA
 NM_028562 RIKEN cDNA 1700080E11 gene (1700080E11Rik), mRNA [NM_028562] KLA .99 1.01 .96 1.00 1.02 1.04 1.06
ATP .96 .98 1.05 1.02 1.00 1.04 1.09
KLA/ATP 1.02 .97 1.03 1.02 1.01 1.06 1.01
AK043052
KLA  ATP  ATP+KLA
 AK043052 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730051E03 product:unclassifiable, full insert sequence. [AK043052] KLA .94 .86 .88 .85 .94 .87 .90
ATP .91 .77 .80 .82 1.20 1.00 .92
KLA/ATP .85 .82 .85 .82 1.20 .91 .86
AK079480
KLA  ATP  ATP+KLA
 AK079480 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130021K15 product:unclassifiable, full insert sequence. [AK079480] KLA 1.00 1.02 .97 .94 .98 1.05 1.02
ATP 1.08 1.01 1.04 .98 1.00 1.02 .99
KLA/ATP .99 1.00 .93 1.03 .97 .98 .93
AK080328
KLA  ATP  ATP+KLA
 AK080328 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630055C19 product:unclassifiable, full insert sequence [AK080328] KLA .93 1.00 1.03 .99 .97 .95 1.05
ATP 1.00 .99 1.02 1.00 1.01 .92 .99
KLA/ATP 1.03 1.01 1.05 .96 1.05 1.00 1.04
AK129128
KLA  ATP  ATP+KLA
 AK079259 adult male urinary bladder cDNA, RIKEN full-length enriched library, clone:9530062M13 product:KIAA0372 PROTEIN homolog [Homo sapiens], full insert sequence. [AK079259] KLA .98 .79 .78 .73 .78 .84 1.03
ATP 1.07 1.00 .72 .64 .79 .84 .86
KLA/ATP .97 1.01 .68 .64 .75 .77 .79
Btg1
KLA  ATP  ATP+KLA
 NM_007569 B-cell translocation gene 1, anti-proliferative (Btg1), mRNA [NM_007569] KLA 1.69 1.79 1.57 1.04 .84 .81 1.28
ATP 1.17 1.50 1.70 3.58 6.87 7.33 2.50
KLA/ATP 1.75 2.17 2.10 3.87 3.75 3.85 4.23
Btg2
KLA  ATP  ATP+KLA
 NM_007570 B-cell translocation gene 2, anti-proliferative (Btg2), mRNA [NM_007570] KLA 1.82 1.76 2.70 3.14 3.01 1.95 1.55
ATP 1.49 2.29 9.42 10.55 2.84 2.30 .74
KLA/ATP 1.96 2.30 7.25 11.30 4.21 2.97 2.20
Btg3
KLA  ATP  ATP+KLA
 NM_009770 B-cell translocation gene 3 (Btg3), mRNA [NM_009770] KLA 1.61 1.64 1.98 2.11 1.99 1.78 2.25
ATP .88 .98 1.42 1.77 2.68 15.33 2.55
KLA/ATP 1.62 1.86 3.07 3.69 4.98 16.03 6.97
Btg4
KLA  ATP  ATP+KLA
 NM_019493 B-cell translocation gene 4 (Btg4), mRNA [NM_019493] KLA .96 .93 1.05 1.03 1.01 1.01 1.00
ATP 1.06 .94 .91 .96 .97 1.01 1.05
KLA/ATP .99 1.05 1.04 .97 .95 .95 .95
C1d
KLA  ATP  ATP+KLA
 NM_020558 nuclear DNA binding protein (C1d), mRNA [NM_020558] KLA 1.18 1.16 1.21 1.21 1.16 1.09 1.06
ATP 1.00 1.03 1.26 1.08 .81 .70 .69
KLA/ATP 1.10 1.16 1.29 1.13 .95 .75 .57
Cnot1
KLA  ATP  ATP+KLA
 XM_894673 gb|PREDICTED: Mus musculus CCR4-NOT transcription complex, subunit 1, transcript variant 2 (Cnot1), mRNA [XM_894673] KLA 1.02 .91 1.06 .93 1.02 1.07 .98
ATP 1.16 1.08 .84 .67 .83 1.00 .78
KLA/ATP 1.07 1.05 .75 .63 .78 .95 .86
Cnot10
KLA  ATP  ATP+KLA
 AK157824 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130064O10 product:CCR4-NOT transcription complex, subunit 10, full insert sequence [AK157824] KLA .70 .64 .61 .68 .89 .99 .91
ATP 1.03 .91 .85 .47 .72 .76 .94
KLA/ATP .69 .60 .64 .52 .83 .73 .79
Cnot10
KLA  ATP  ATP+KLA
 NM_153585 CCR4-NOT transcription complex, subunit 10 (Cnot10), mRNA [NM_153585] KLA .78 .80 .80 .71 .71 .83 .87
ATP 1.02 1.09 1.06 1.17 .91 .97 .99
KLA/ATP .83 .85 .75 .84 .68 .99 .87
Cnot2
KLA  ATP  ATP+KLA
 NM_001037846 CCR4-NOT transcription complex, subunit 2 (Cnot2), transcript variant 1, mRNA [NM_001037846] KLA 1.24 1.18 1.21 1.18 1.02 1.02 1.11
ATP 1.03 .98 1.11 .82 .90 .86 .71
KLA/ATP 1.22 1.18 1.32 .91 .95 .88 .77
Cnot2
KLA  ATP  ATP+KLA
 NM_001037847 CCR4-NOT transcription complex, subunit 2 (Cnot2), transcript variant 2, mRNA [NM_001037847] KLA 1.38 1.34 1.59 1.39 1.33 1.28 1.36
ATP 1.17 1.30 1.10 1.27 1.13 1.22 1.30
KLA/ATP 1.67 1.63 1.29 1.66 1.10 1.45 2.08
Cnot3
KLA  ATP  ATP+KLA
 NM_146176 CCR4-NOT transcription complex, subunit 3 (Cnot3), mRNA [NM_146176] KLA .99 .99 1.02 1.05 1.16 1.18 1.15
ATP 1.08 1.14 .92 1.09 .97 1.19 1.04
KLA/ATP 1.11 1.05 .93 1.16 1.02 1.20 1.29
Cnot4
KLA  ATP  ATP+KLA
 BC058778 CCR4-NOT transcription complex, subunit 4, mRNA (cDNA clone MGC:65243 IMAGE:5397231), complete cds [BC058778] KLA 1.77 1.78 1.72 1.41 1.34 1.46 1.79
ATP 1.04 1.15 1.23 1.67 2.29 1.81 1.80
KLA/ATP 1.89 2.05 1.69 2.41 2.87 2.27 2.60
Cnot4
KLA  ATP  ATP+KLA
 NM_016877 CCR4-NOT transcription complex, subunit 4 (Cnot4), mRNA [NM_016877] KLA 1.65 1.47 1.31 1.34 1.28 1.18 1.30
ATP 1.08 1.06 1.44 1.59 2.59 1.69 1.21
KLA/ATP 1.59 1.67 2.17 1.96 2.90 1.96 1.57
Cnot6
KLA  ATP  ATP+KLA
 BC037217 CCR4-NOT transcription complex, subunit 6, mRNA (cDNA clone IMAGE:5355497), with apparent retained intron [BC037217] KLA .84 .77 .80 .82 .69 .63 .68
ATP 1.09 .97 1.00 .67 .74 .65 .64
KLA/ATP .88 .80 .88 .57 .62 .47 .52
Cnot6
KLA  ATP  ATP+KLA
 NM_212484 CCR4-NOT transcription complex, subunit 6 (Cnot6), mRNA [NM_212484] KLA 1.04 1.03 .97 .98 .93 .88 .80
ATP 1.23 1.16 .91 .94 .96 .95 .80
KLA/ATP 1.11 1.12 .96 .97 1.05 .82 .92
Cnot6l
KLA  ATP  ATP+KLA
 NM_144910 CCR4-NOT transcription complex, subunit 6-like (Cnot6l), transcript variant 1, mRNA [NM_144910] KLA .81 .76 .69 .79 .60 .71 .59
ATP .88 .75 1.06 .73 .70 .66 .54
KLA/ATP .62 .67 .90 .70 1.10 .73 .53
Cnot6l
KLA  ATP  ATP+KLA
 NM_178854 CCR4-NOT transcription complex, subunit 6-like (Cnot6l), transcript variant 2, mRNA [NM_178854] KLA .91 .95 .93 .94 .77 .81 .69
ATP 1.01 .94 1.18 .84 .84 .88 .72
KLA/ATP .83 .86 1.09 .84 1.19 .94 .69
Cnot7
KLA  ATP  ATP+KLA
 NM_011135 CCR4-NOT transcription complex, subunit 7 (Cnot7), mRNA [NM_011135] KLA 1.66 1.63 1.85 1.55 1.43 1.10 1.38
ATP 1.10 1.24 1.00 1.18 1.09 .99 .94
KLA/ATP 1.63 1.83 1.29 1.63 1.05 .90 1.00
Cnot8
KLA  ATP  ATP+KLA
 NM_026949 CCR4-NOT transcription complex, subunit 8 (Cnot8), mRNA [NM_026949] KLA 1.02 1.02 1.13 1.05 1.18 1.29 1.28
ATP 1.10 1.07 .87 .94 .89 1.33 1.57
KLA/ATP 1.13 1.12 1.00 1.08 1.11 1.57 2.10
Dcp1a
KLA  ATP  ATP+KLA
 NM_133761 DCP1 decapping enzyme homolog A (S. cerevisiae) (Dcp1a), mRNA [NM_133761] KLA 2.92 2.89 2.91 2.41 1.99 1.60 1.40
ATP 1.01 1.14 1.06 .89 1.27 1.89 1.37
KLA/ATP 2.84 2.97 2.50 2.11 1.87 2.79 2.20
Dcp1b
KLA  ATP  ATP+KLA
 NM_001033379 DCP1 decapping enzyme homolog b (S. cerevisiae) (Dcp1b), mRNA [NM_001033379] KLA .83 .77 .82 .86 .97 1.12 1.25
ATP .90 .83 .89 .75 .48 .51 .79
KLA/ATP .71 .68 .69 .62 .51 .58 1.03
Dcp2
KLA  ATP  ATP+KLA
 XM_140308 gb|PREDICTED: Mus musculus DCP2 decapping enzyme homolog (S. cerevisiae) (Dcp2), mRNA [XM_140308] KLA 7.05 6.67 7.58 7.71 6.77 5.63 2.88
ATP 1.05 .97 1.10 1.10 1.04 3.92 3.18
KLA/ATP 6.64 6.96 6.95 6.33 4.43 6.24 9.56
Dcps
KLA  ATP  ATP+KLA
 NM_027030 decapping enzyme, scavenger (Dcps), mRNA [NM_027030] KLA .91 .90 .82 .84 .70 .66 .70
ATP .97 1.00 1.23 1.37 .92 .59 .50
KLA/ATP .87 .90 1.13 1.04 .94 .68 .41
Ddx6
KLA  ATP  ATP+KLA
 NM_181324 DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 (Ddx6), transcript variant 2, mRNA [NM_181324] KLA 1.15 1.24 1.05 1.36 1.55 1.44 1.11
ATP 1.19 1.27 1.26 1.45 1.79 1.82 1.49
KLA/ATP 1.33 1.32 1.39 1.68 1.64 1.82 2.64
Dhx36
KLA  ATP  ATP+KLA
 AK029289 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832414O22 product:unclassifiable, full insert sequence [AK029289] KLA 1.00 .93 .85 .83 1.00 .96 .94
ATP .89 .78 .70 .68 .97 .93 .89
KLA/ATP .83 .69 .72 .73 .92 .92 .85
Dhx36
KLA  ATP  ATP+KLA
 NM_028136 DEAH (Asp-Glu-Ala-His) box polypeptide 36 (Dhx36), mRNA [NM_028136] KLA 1.17 1.13 1.09 1.09 1.07 .97 1.06
ATP 1.09 1.08 1.18 1.05 .83 .97 1.02
KLA/ATP 1.06 1.17 1.31 1.05 .73 .96 1.01
Dis3
KLA  ATP  ATP+KLA
 NM_028315 DIS3 mitotic control homolog (S. cerevisiae) (Dis3), mRNA [NM_028315] KLA .87 .85 .70 .73 .55 .58 .67
ATP .95 .93 .98 .84 .84 .78 .57
KLA/ATP .78 .78 .75 .62 .50 .46 .34
Edc3
KLA  ATP  ATP+KLA
 AK090005 submandibular gland CRL-1734 SCA-9 clone 15 cDNA, RIKEN full-length enriched library, clone:G430056N18 product:hypothetical YjeF-like structure containing protein, full insert sequence. [AK090005] KLA 1.00 1.00 1.00 .96 1.03 .92 1.00
ATP .97 1.11 .91 .90 .84 1.06 .98
KLA/ATP .98 .94 .93 .95 .86 .91 1.04
Edc3
KLA  ATP  ATP+KLA
 NM_153799 enhancer of mRNA decapping 3 homolog (S. cerevisiae) (Edc3), mRNA [NM_153799] KLA .97 1.00 1.20 1.21 1.42 1.41 1.20
ATP 1.01 .91 .54 .52 .76 1.25 1.26
KLA/ATP 1.08 .94 .58 .65 .85 1.51 1.60
Edc4
KLA  ATP  ATP+KLA
 NM_181594 enhancer of mRNA decapping 4 (Edc4), mRNA [NM_181594] KLA 1.51 1.26 1.23 1.26 1.04 1.03 .93
ATP .96 .87 1.10 .93 1.07 1.59 1.02
KLA/ATP 1.17 1.27 1.35 1.09 1.09 1.39 1.17
Eno1
KLA  ATP  ATP+KLA
 NM_023119 enolase 1, alpha non-neuron (Eno1), mRNA [NM_023119] KLA .95 1.06 1.16 .78 1.04 .91 1.33
ATP 1.32 1.63 .81 1.78 1.08 1.07 1.65
KLA/ATP 1.50 1.43 .46 1.67 .61 1.02 1.97
Eno2
KLA  ATP  ATP+KLA
 NM_013509 enolase 2, gamma neuronal (Eno2), mRNA [NM_013509] KLA .84 .85 .72 .81 1.23 1.24 2.08
ATP 1.07 1.13 1.14 3.24 4.11 1.61 2.43
KLA/ATP .93 .89 .85 1.68 3.37 1.66 2.69
Eno3
KLA  ATP  ATP+KLA
 NM_007933 enolase 3, beta muscle (Eno3), mRNA [NM_007933] KLA .85 .86 .88 .84 .67 .70 1.00
ATP .92 .90 1.28 1.20 .96 .59 .68
KLA/ATP .82 .90 1.10 .99 .94 .52 .51
Exosc1
KLA  ATP  ATP+KLA
 NM_025644 exosome component 1 (Exosc1), mRNA [NM_025644] KLA .69 .69 .58 .63 .62 .72 1.17
ATP 1.04 1.10 .94 .81 .64 .71 .91
KLA/ATP .66 .70 .74 .66 .48 .42 .51
Exosc10
KLA  ATP  ATP+KLA
 NM_016699 exosome component 10 (Exosc10), mRNA [NM_016699] KLA 1.09 1.08 1.11 .94 1.03 .97 1.12
ATP 1.03 1.06 .99 1.20 1.00 .76 .74
KLA/ATP 1.15 1.19 1.00 1.26 .95 .71 .62
Exosc2
KLA  ATP  ATP+KLA
 NM_144886 exosome component 2 (Exosc2), mRNA [NM_144886] KLA .65 .70 .64 .62 .56 .60 .82
ATP .90 .91 .95 .96 .56 .55 .65
KLA/ATP .64 .71 .75 .73 .55 .41 .33
Exosc3
KLA  ATP  ATP+KLA
 AK016397 adult male testis cDNA, RIKEN full-length enriched library, clone:4930596A03 product:hypothetical protein, full insert sequence. [AK016397] KLA .88 .91 .91 .88 .95 .89 .86
ATP .90 .90 .90 .92 .99 1.02 .89
KLA/ATP .89 .82 .92 .94 1.03 1.02 .96
Exosc3
KLA  ATP  ATP+KLA
 NM_025513 exosome component 3 (Exosc3), mRNA [NM_025513] KLA 1.18 1.16 1.24 1.36 1.31 1.29 1.25
ATP 1.05 1.02 1.12 1.07 1.03 1.24 1.13
KLA/ATP 1.18 1.13 1.51 1.26 1.10 1.17 .97
Exosc4
KLA  ATP  ATP+KLA
 NM_175399 exosome component 4 (Exosc4), mRNA [NM_175399] KLA .92 .89 .88 .95 1.00 1.05 1.22
ATP .89 .90 .79 .74 .70 1.27 1.26
KLA/ATP .88 .88 .81 .85 .84 1.26 1.38
Exosc5
KLA  ATP  ATP+KLA
 AK143763 6 days neonate spleen cDNA, RIKEN full-length enriched library, clone:F430103P08 product:unclassifiable, full insert sequence. [AK143763] KLA .90 .94 .92 .90 .90 .88 .92
ATP 1.08 .99 .86 .85 .92 .96 .87
KLA/ATP .90 .96 .89 .98 .90 .86 .85
Exosc5
KLA  ATP  ATP+KLA
 NM_138586 exosome component 5 (Exosc5), mRNA [NM_138586] KLA .69 .68 .62 .64 .50 .48 .67
ATP .95 .97 1.15 1.18 .74 .40 .55
KLA/ATP .67 .68 .76 .79 .62 .39 .38
Exosc6
KLA  ATP  ATP+KLA
 NM_028274 exosome component 6 (Exosc6), mRNA [NM_028274] KLA .30 .28 .22 .24 .25 .34 .53
ATP 1.00 1.00 .96 .70 .74 1.11 .65
KLA/ATP .33 .30 .28 .27 .24 .43 .27
Exosc7
KLA  ATP  ATP+KLA
 AK085426 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630024I10 product:Hypothetical 3 exoribonuclease family containing protein, full insert sequence [AK085426] KLA .90 .99 .99 .92 .92 .95 1.03
ATP .98 .93 .93 1.06 1.02 .94 .94
KLA/ATP .96 .95 .92 .97 .91 .97 1.06
Exosc7
KLA  ATP  ATP+KLA
 NM_001081188 exosome component 7 (Exosc7), mRNA [NM_001081188] KLA .62 .59 .58 .54 .56 .63 .78
ATP .91 .95 .99 .98 .47 .47 .69
KLA/ATP .55 .60 .66 .62 .46 .41 .38
Exosc8
KLA  ATP  ATP+KLA
 AK047257 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930042L20 product:unclassifiable, full insert sequence [AK047257] KLA .77 .74 .71 .60 .72 .75 .85
ATP 1.02 1.11 1.00 .72 .73 .67 .84
KLA/ATP .73 .71 .74 .64 .66 .65 .67
Exosc8
KLA  ATP  ATP+KLA
 NM_027148 exosome component 8 (Exosc8), mRNA [NM_027148] KLA .79 .78 .71 .60 .44 .44 .56
ATP .88 .88 1.16 1.11 .83 .60 .49
KLA/ATP .69 .75 .97 .77 .72 .40 .28
Exosc9
KLA  ATP  ATP+KLA
 AK083794 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130011I06 product:polymyositis/scleroderma autoantigen 1, full insert sequence. [AK083794] KLA 1.00 .97 .95 1.00 .95 .95 1.02
ATP 1.13 1.06 .89 .85 .87 .89 .99
KLA/ATP .99 .99 .89 .89 .87 .91 .99
Exosc9
KLA  ATP  ATP+KLA
 NM_019393 exosome component 9 (Exosc9), mRNA [NM_019393] KLA 1.29 1.31 1.25 1.29 1.05 .92 1.04
ATP .96 .95 1.08 1.02 .81 .86 .81
KLA/ATP 1.22 1.31 1.40 1.37 1.04 .67 .52
Hspa9
KLA  ATP  ATP+KLA
 NM_010481 heat shock protein 9 (Hspa9), nuclear gene encoding mitochondrial protein, mRNA [NM_010481] KLA .74 .80 .73 .57 .53 .59 1.24
ATP .96 1.07 1.02 .99 1.38 1.08 .84
KLA/ATP .78 .84 .70 .69 .70 .61 .54
Hspd1
KLA  ATP  ATP+KLA
 NM_010477 heat shock protein 1 (chaperonin) (Hspd1), nuclear gene encoding mitochondrial protein, mRNA [NM_010477] KLA .86 .89 .76 .67 .65 .60 .91
ATP 1.12 1.15 .98 .92 .91 .71 .64
KLA/ATP .86 .97 .82 .74 .56 .38 .34
Lsm1
KLA  ATP  ATP+KLA
 NM_026032 LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm1), mRNA [NM_026032] KLA .92 .91 .94 1.01 1.04 1.20 1.07
ATP .96 .98 1.24 1.09 1.10 1.71 1.31
KLA/ATP .86 .91 1.13 1.02 1.26 1.64 1.42
Lsm2
KLA  ATP  ATP+KLA
 NM_030597 LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm2), transcript variant 1, mRNA [NM_030597] KLA .83 .80 .81 .74 .57 .52 .58
ATP 1.09 1.08 1.07 1.27 .85 .67 .38
KLA/ATP .90 .92 .84 .89 .68 .52 .36
Lsm3
KLA  ATP  ATP+KLA
 NM_026309 LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm3), mRNA [NM_026309] KLA .95 .94 1.01 .96 1.08 1.14 .74
ATP 1.03 .99 1.42 1.26 .99 1.08 .72
KLA/ATP .97 .91 1.47 1.21 1.27 1.05 .83
Lsm4
KLA  ATP  ATP+KLA
 NM_015816 LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm4), mRNA [NM_015816] KLA .93 .95 .86 .90 .77 .72 .64
ATP 1.01 .96 1.06 1.12 1.03 .68 .49
KLA/ATP .96 .91 1.03 1.04 1.00 .74 .31
Lsm5
KLA  ATP  ATP+KLA
 NM_025520 LSM5 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm5), mRNA [NM_025520] KLA 1.06 .97 .96 1.00 .75 .52 .47
ATP .91 1.03 1.36 1.42 1.09 .76 .44
KLA/ATP .94 1.06 1.25 1.38 1.11 .73 .34
Lsm6
KLA  ATP  ATP+KLA
 NM_030145 LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm6), mRNA [NM_030145] KLA 1.17 1.13 1.02 1.10 .84 .69 .62
ATP .87 .89 1.11 1.02 .96 .97 .73
KLA/ATP 1.01 1.15 1.33 1.05 1.02 .90 .58
Lsm7
KLA  ATP  ATP+KLA
 NM_025349 LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm7), mRNA [NM_025349] KLA .77 .78 .73 .73 .64 .61 .72
ATP .89 .90 1.14 1.23 .94 .57 .61
KLA/ATP .77 .76 1.00 1.00 .94 .58 .30
Lsm8
KLA  ATP  ATP+KLA
 NM_133939 LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae) (Lsm8), mRNA [NM_133939] KLA 1.04 1.09 1.16 1.19 1.05 1.02 .78
ATP .94 .98 1.23 1.14 .80 .73 .54
KLA/ATP .99 1.11 1.42 1.47 .87 .59 .57
Mm.23639
2
KLA  ATP  ATP+KLA
 83000436 Unknown KLA 1.79 1.93 1.76 1.33 1.07 .98 1.42
ATP 1.21 1.60 1.62 3.39 5.75 5.27 2.13
KLA/ATP 1.94 2.51 1.98 3.75 3.04 2.97 3.15
Mm.25019
7
KLA  ATP  ATP+KLA
 141802049 Unknown KLA .76 .70 .72 .92 .87 1.09 1.14
ATP .83 .74 .98 .70 .38 .48 .68
KLA/ATP .64 .59 .72 .55 .50 .57 .96
Mm.26706
1
KLA  ATP  ATP+KLA
 161016794 Unknown KLA .72 .76 .70 .89 1.01 1.06 .99
ATP .99 1.00 1.15 .89 1.47 2.03 .98
KLA/ATP .74 .79 .85 .76 1.43 1.81 1.46
Mm.28694
KLA  ATP  ATP+KLA
 141802913 Unknown KLA 1.00 .98 1.03 .95 .87 .93 .87
ATP .98 1.04 .93 .90 .95 .99 .86
KLA/ATP 1.00 1.02 .97 .85 .86 .85 .84
Mm.28908
6
KLA  ATP  ATP+KLA
 31981244 Unknown KLA .69 .70 .59 .56 .54 .69 1.08
ATP .93 .98 .92 .81 .57 .64 .98
KLA/ATP .65 .68 .64 .60 .45 .43 .40
Mm.33481
0
KLA  ATP  ATP+KLA
 195546958 Unknown KLA .32 .30 .23 .24 .24 .35 .56
ATP .90 .91 1.03 .70 .69 1.11 .60
KLA/ATP .29 .32 .31 .25 .29 .57 .27
Mm.39291
0
KLA  ATP  ATP+KLA
 118130269 Unknown KLA 1.84 1.69 1.89 2.25 2.06 1.90 2.16
ATP .83 .81 1.51 1.61 3.09 25.30 2.78
KLA/ATP 1.65 1.83 4.14 4.30 7.62 27.67 9.14
Mm.43131
7
KLA  ATP  ATP+KLA
 142353275 Unknown KLA 1.04 1.07 .98 1.00 1.04 .98 1.00
ATP .95 1.01 1.01 .99 .96 1.01 .93
KLA/ATP .98 1.06 1.01 .96 .89 .99 1.05
Mphosph6
KLA  ATP  ATP+KLA
 NM_026758 M phase phosphoprotein 6 (Mphosph6), mRNA [NM_026758] KLA 1.32 1.31 1.17 1.10 .83 .72 .78
ATP .95 .87 1.31 1.11 1.13 1.13 .86
KLA/ATP 1.14 1.29 1.63 1.28 1.36 .95 .63
Nudt16
KLA  ATP  ATP+KLA
 NM_029385 nudix (nucleoside diphosphate linked moiety X)-type motif 16 (Nudt16), mRNA [NM_029385] KLA .74 .80 .89 .93 1.05 1.11 1.22
ATP .90 .80 .75 .75 .40 .52 1.09
KLA/ATP .68 .64 .63 .68 .48 .64 1.59
Pabpc1
KLA  ATP  ATP+KLA
 AK005009 adult male liver cDNA, RIKEN full-length enriched library, clone:1300015A08 product:poly A binding protein, cytoplasmic 1, full insert sequence [AK005009] KLA 1.13 1.21 1.13 1.02 1.40 1.23 1.50
ATP 1.75 1.90 2.87 2.53 3.50 1.80 1.06
KLA/ATP 1.88 2.43 3.09 2.31 2.25 1.68 1.47
Pabpc1
KLA  ATP  ATP+KLA
 NM_008774 poly A binding protein, cytoplasmic 1 (Pabpc1), mRNA [NM_008774] KLA 1.28 1.27 1.07 1.22 1.13 .99 .92
ATP .99 .91 1.04 .85 1.11 .95 .57
KLA/ATP 1.27 1.10 1.34 1.16 1.13 .82 .78
Pabpc2
KLA  ATP  ATP+KLA
 NM_011033 poly A binding protein, cytoplasmic 2 (Pabpc2), mRNA [NM_011033] KLA 1.24 1.21 1.22 1.20 1.14 .98 .99
ATP 1.00 .98 1.12 1.13 1.24 1.07 .80
KLA/ATP 1.21 1.20 1.37 1.42 1.35 1.17 .96
Pabpc3
KLA  ATP  ATP+KLA
 AK016578 adult male testis cDNA, RIKEN full-length enriched library, clone:4932702K14 product:POLY A BINDING PROTEIN, CYTOPLASMIC 1 homolog [Mus musculus], full insert sequence [AK016578] KLA .99 1.01 .98 1.03 1.04 1.00 .95
ATP .98 1.05 1.00 .98 .98 .99 1.04
KLA/ATP .99 .98 1.01 .96 .94 1.02 1.05
Pabpc4
KLA  ATP  ATP+KLA
 NM_148917 poly A binding protein, cytoplasmic 4 (Pabpc4), transcript variant 2, mRNA [NM_148917] KLA .99 1.01 .91 .75 .56 .45 .55
ATP .99 1.11 1.00 1.32 1.41 1.20 .50
KLA/ATP 1.00 1.03 .80 .96 .84 .74 .49
Pabpc4l
KLA  ATP  ATP+KLA
 NM_001101479 poly(A) binding protein, cytoplasmic 4-like (Pabpc4l), mRNA [NM_001101479] KLA 1.00 1.01 1.02 1.02 .96 .96 .95
ATP 1.03 .95 1.84 1.06 .93 .99 .99
KLA/ATP 1.03 1.00 1.07 1.05 1.00 .93 1.02
Pabpc5
KLA  ATP  ATP+KLA
 NM_053114 poly A binding protein, cytoplasmic 5 (Pabpc5), mRNA [NM_053114] KLA 1.00 1.02 1.03 .99 .95 .96 .97
ATP .95 1.05 .99 .97 1.00 1.03 1.01
KLA/ATP .99 .96 1.00 1.04 .95 .98 1.02
Pan3
KLA  ATP  ATP+KLA
 AK039912 0 day neonate thymus cDNA, RIKEN full-length enriched library, clone:A430027N15 product:unclassifiable, full insert sequence. [AK039912] KLA 1.10 1.00 .99 1.00 1.00 .99 .94
ATP .96 1.06 1.06 .98 1.02 1.00 1.03
KLA/ATP 1.02 .93 1.05 1.02 1.04 .90 1.05
Pan3
KLA  ATP  ATP+KLA
 NM_028291 PAN3 polyA specific ribonuclease subunit homolog (S. cerevisiae) (Pan3), mRNA [NM_028291] KLA 1.14 1.04 1.04 1.03 1.00 1.01 1.03
ATP 1.15 1.12 1.19 1.24 1.49 1.85 1.06
KLA/ATP 1.13 1.23 1.27 1.15 1.33 1.78 1.65
Parn
KLA  ATP  ATP+KLA
 NM_028761 poly(A)-specific ribonuclease (deadenylation nuclease) (Parn), mRNA [NM_028761] KLA .92 .92 .98 .94 .86 .75 .77
ATP 1.10 1.09 1.15 1.09 .78 .59 .75
KLA/ATP .96 1.01 1.07 .94 .72 .58 .59
Patl1
KLA  ATP  ATP+KLA
 NM_172635 protein associated with topoisomerase II homolog 1 (yeast) (Patl1), mRNA [NM_172635] KLA 1.28 1.26 1.43 1.36 1.43 1.62 1.45
ATP 1.03 1.11 .97 2.48 3.72 1.82 1.25
KLA/ATP 1.34 1.39 .99 2.20 3.20 2.40 1.79
Pnpt1
KLA  ATP  ATP+KLA
 AK085482 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630033G07 product:unclassifiable, full insert sequence. [AK085482] KLA .98 1.03 1.04 .98 1.03 1.03 1.01
ATP .97 .98 .96 1.02 .95 1.01 .98
KLA/ATP 1.02 1.08 1.01 1.00 1.00 1.06 1.03
Pnpt1
KLA  ATP  ATP+KLA
 NM_027869 polyribonucleotide nucleotidyltransferase 1 (Pnpt1), mRNA [NM_027869] KLA 3.44 3.41 4.04 3.56 2.94 2.53 2.01
ATP 1.06 1.07 1.19 1.24 .74 1.53 1.24
KLA/ATP 3.55 4.25 4.40 4.20 2.57 2.41 2.01
Pols
KLA  ATP  ATP+KLA
 NM_198600 polymerase (DNA directed) sigma (Pols), mRNA [NM_198600] KLA 6.77 6.15 5.90 4.16 3.49 3.37 2.22
ATP 1.04 1.05 1.04 .67 1.19 2.08 1.49
KLA/ATP 6.69 6.85 5.68 3.81 5.14 2.75 1.93
Rqcd1
KLA  ATP  ATP+KLA
 NM_021383 rcd1 (required for cell differentiation) homolog 1 (S. pombe) (Rqcd1), mRNA [NM_021383] KLA .76 .83 .88 .80 .95 1.03 .97
ATP 1.20 1.23 .89 1.23 1.15 1.09 .84
KLA/ATP .87 .96 .62 .84 .99 1.35 .83
Skiv2l
KLA  ATP  ATP+KLA
 NM_021337 superkiller viralicidic activity 2-like (S. cerevisiae) (Skiv2l), mRNA [NM_021337] KLA 1.03 1.08 1.29 1.21 1.32 1.31 1.12
ATP 1.10 1.02 1.06 1.09 1.04 .76 1.16
KLA/ATP 1.14 1.18 1.31 1.30 1.26 1.02 1.20
Skiv2l2
KLA  ATP  ATP+KLA
 AK077924 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030446B09 product:hypothetical P-loop containing nucleotide triphosphate hydrolases structure containing protein, full insert sequence. [AK077924] KLA 1.02 .98 .92 .94 .95 .94 .95
ATP .99 .91 .89 .95 .98 .97 .95
KLA/ATP .95 .96 .87 .84 .96 .97 .95
Skiv2l2
KLA  ATP  ATP+KLA
 NM_028151 superkiller viralicidic activity 2-like 2 (S. cerevisiae) (Skiv2l2), mRNA [NM_028151] KLA 1.31 1.28 1.14 1.00 .83 .91 .91
ATP .97 1.02 1.20 .98 .94 1.03 .75
KLA/ATP 1.25 1.35 1.35 1.06 .90 .89 .67
Tob1
KLA  ATP  ATP+KLA
 NM_009427 transducer of ErbB-2.1 (Tob1), mRNA [NM_009427] KLA .68 .73 .66 .82 .86 .74 .83
ATP 1.13 1.31 2.34 4.63 3.88 1.20 1.09
KLA/ATP .78 .79 1.89 5.61 4.02 1.52 1.58
Tob2
KLA  ATP  ATP+KLA
 NM_020507 transducer of ERBB2, 2 (Tob2), mRNA [NM_020507] KLA .72 .84 .71 1.06 1.30 1.09 .90
ATP 1.06 1.34 1.33 2.08 3.46 1.07 .89
KLA/ATP .74 .84 .76 1.76 3.95 1.24 1.12
Usp52
KLA  ATP  ATP+KLA
 AK034635 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430017A16 product:inferred: RIKEN cDNA 1200014O24 gene, full insert sequence. [AK034635] KLA 1.01 1.01 1.12 1.07 1.07 1.04 .96
ATP 1.04 .95 .95 .90 .89 .96 1.03
KLA/ATP 1.07 1.09 1.00 .88 .93 .94 1.04
Usp52
KLA  ATP  ATP+KLA
 NM_133992 ubiquitin specific peptidase 52 (Usp52), mRNA [NM_133992] KLA .97 .99 1.08 1.00 1.16 1.08 .93
ATP 1.06 1.14 1.01 1.21 .93 .98 .80
KLA/ATP 1.00 1.10 .96 1.34 1.45 1.39 1.25
Wdr61
KLA  ATP  ATP+KLA
 AK077037 adult male testis cDNA, RIKEN full-length enriched library, clone:4932422L05 product:MEIOTIC RECOMBINATION PROTEIN REC14 (2810418I05RIK PROTEIN) homolog [Mus musculus], full insert sequence [AK077037] KLA .97 .95 .94 .98 1.03 .98 .95
ATP 1.02 .94 .93 .97 1.01 1.03 1.06
KLA/ATP .96 .98 .96 .92 .92 1.00 .97
Wdr61
KLA  ATP  ATP+KLA
 NM_001025375 WD repeat domain 61 (Wdr61), transcript variant 1, mRNA [NM_001025375] KLA 1.00 .99 .93 .88 .76 .73 .92
ATP .91 .89 .96 .88 .74 .67 .84
KLA/ATP .94 .95 1.01 .88 .76 .53 .52
Xrn1
KLA  ATP  ATP+KLA
 NM_011916 5-3 exoribonuclease 1 (Xrn1), mRNA [NM_011916] KLA 3.08 3.27 3.28 2.83 2.53 1.91 1.35
ATP 1.12 1.17 1.09 .93 .71 1.21 .95
KLA/ATP 3.21 3.42 2.92 2.50 1.70 2.17 2.25
Xrn2
KLA  ATP  ATP+KLA
 AK031247 13 days embryo forelimb cDNA, RIKEN full-length enriched library, clone:5930437B06 product:5-3 exoribonuclease 2, full insert sequence [AK031247] KLA 1.84 1.84 1.98 1.97 1.81 1.55 1.30
ATP .97 1.04 1.07 .95 .84 .79 .59
KLA/ATP 1.69 1.92 1.93 1.85 1.48 1.13 .67
Xrn2
KLA  ATP  ATP+KLA
 NM_011917 5-3 exoribonuclease 2 (Xrn2), mRNA [NM_011917] KLA 2.26 2.19 2.72 2.61 2.29 1.83 1.48
ATP 1.24 1.26 .91 1.08 .93 1.00 .95
KLA/ATP 2.15 2.40 2.01 2.45 1.47 1.41 1.19
Zcchc7
KLA  ATP  ATP+KLA
 NM_138590 zinc finger, CCHC domain containing 7 (Zcchc7), transcript variant 1, mRNA [NM_138590] KLA 1.77 1.50 1.24 1.04 .88 .92 .86
ATP .99 1.01 1.79 1.44 .70 1.08 .83
KLA/ATP 1.30 1.48 2.27 1.57 .69 .73 .79
Zcchc7
KLA  ATP  ATP+KLA
 NM_177027 zinc finger, CCHC domain containing 7 (Zcchc7), transcript variant 2, mRNA [NM_177027] KLA 1.47 1.28 1.16 1.05 1.01 1.09 1.06
ATP 1.03 1.01 1.31 1.09 .76 .96 1.00
KLA/ATP 1.35 1.40 1.44 .99 .73 .83 .91